{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:57:40Z","timestamp":1789095460310,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer New York","isbn-type":[{"value":"9781441916624","type":"print"},{"value":"9781441916648","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-4419-1664-8_8","type":"book-chapter","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T02:30:31Z","timestamp":1280370631000},"page":"79-86","source":"Crossref","is-referenced-by-count":12,"title":["The Role of Menin in Parathyroid Tumorigenesis"],"prefix":"10.1007","author":[{"given":"Colin","family":"Davenport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMcp032200","volume":"350","author":"J.P. Bilezikian","year":"2004","unstructured":"Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 2004; 350:1746\u20131751.","journal-title":"N Engl J Med"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1210\/jc.2003-031184","volume":"89","author":"K. Yao","year":"2004","unstructured":"Yao K, Singer FR, Roth SI et al. Weight of normal parathyroid glands in patients with parathyroid adenomas. J Clin Endocrinol Metab 2004; 89:3208\u20133213.","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI10523","volume":"107","author":"Y. Imanishi","year":"2001","unstructured":"Imanishi Y, Hosokawa Y, Yoshimoto K et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Investig 2001; 107:1093\u2013102.","journal-title":"J Clin Investig"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6823-7-8","volume":"7","author":"J. Costa-Guda","year":"2007","unstructured":"Costa-Guda J, Tokura T, Roth SI et al. Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. BMC Endocr Disord 2007; 7:8.","journal-title":"BMC Endocr Disord"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1210\/jc.81.9.3194","volume":"81","author":"C. Dotzenrath","year":"1996","unstructured":"Dotzenrath C, Teh BT, Farnebo F et al. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 1996; 81:3194\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/332085a0","volume":"332","author":"C. Larsson","year":"1988","unstructured":"Larsson C, Skogseid B, Oberg K et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (Lond) 1988; 332:85\u20137.","journal-title":"Nature (Lond)"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","volume":"86","author":"M.L. Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86:5658\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ng0897-375","volume":"16","author":"C. Heppner","year":"1997","unstructured":"Heppner C, Kester MB, Agarwal SK et al. Somatic mutation of the MEN1 gene in parathyroid tumors. Nat Genet 1997; 16:375\u20138.","journal-title":"Nat Genet"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1210\/jc.83.8.2627","volume":"83","author":"F. Farnebo","year":"1998","unstructured":"Farnebo F, Teh B, Kytola S et al. Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 1998; 83:2627\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"8_CR10","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-03-3334","volume":"64","author":"H. Sowa","year":"2004","unstructured":"Sowa H, Kaji H, Kitazawa R et al. Menin inactivation leads to loss of transforming growth factor \u03b2 inhibition of parathyroid cell proliferation and parathyroid hormone secretion. Cancer Res 2004; 64(6):2222\u20138.","journal-title":"Cancer Res"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"M.C. Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Murat 2008; 29:22\u201332.","journal-title":"Hum Murat"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1385\/ENDO:29:3:485","volume":"29","author":"J. Naito","year":"2006","unstructured":"Naito J, Kaji H, Sowa H et al. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene. Endocrine 2006; 29:485\u201390.","journal-title":"Endocrine"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1210\/jc.85.7.2615","volume":"85","author":"M.M. Bhuiyan","year":"2000","unstructured":"Bhuiyan MM, Sato M, Murao K et al. Expression of menin in parathyroid tumors. J Clin Endocrinol Metab 2000; 85:2615\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.biocel.2007.09.006","volume":"40","author":"S. Ross","year":"2008","unstructured":"Ross S, Hill CS. How the Smads regulate transcription. Int J Biochem Cell Biol 2008; 40:383\u2013408","journal-title":"Int J Biochem Cell Biol"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1073\/pnas.061358098","volume":"98","author":"H. Kaji","year":"2001","unstructured":"Kaji H, Canaff L, Lebrun JJ et al. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type \u03b2 signalling. Proc Natl Acad Sci USA 2001; 98:3837\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1210\/jc.87.8.3911","volume":"87","author":"T.M. Shattuck","year":"2002","unstructured":"Shattuck TM, Costa J, Bernstein M et al. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-\u03b2 and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. J Clin Endocrinol Metab 2002; 87:3911\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.1074\/jbc.M011033200","volume":"276","author":"N. Subramaniam","year":"2001","unstructured":"Subramaniam N, Leong GM, Cock TA et al. Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-\u03b2 signalling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements. J Biol Chem 2001; 276:15741\u20136.","journal-title":"J Biol Chem"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1210\/endo-125-2-935","volume":"125","author":"R. Kremer","year":"1989","unstructured":"Kremer R, Bolivar I, Goltzman D et al. Influence of calcium and 1, 25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989; 125:935\u201341.","journal-title":"Endocrinology"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1172\/JCI117890","volume":"95","author":"A. Arnold","year":"1995","unstructured":"Arnold A, Brown MF, Urena P et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Investig 1995; 95:2047\u201353.","journal-title":"J Clin Investig"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ki.1993.256","volume":"44","author":"T.D. Malachi","year":"1993","unstructured":"Malachi TD, Zevi U, Gafter A et al. DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int 1993; 44:385\u2013389.","journal-title":"Kidney Int"},{"key":"8_CR21","first-page":"965","volume":"90","author":"L. Shan","year":"1999","unstructured":"Shan L, Nakamura Y, Murakami M et al. Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality Jpn. J Cancer Res 1999; 90:965\u20139.","journal-title":"J Cancer Res"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.85.11.4113","volume":"85","author":"H. Tahara","year":"2000","unstructured":"Tahara H, Imanishi Y, Yamada T et al. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia. J Clin Endocrinol Metab 2000; 85:4113\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/01.ASN.0000018148.50109.C0","volume":"13","author":"Y. Imanishi","year":"2002","unstructured":"Imanishi Y, Tahara H, Palanisamy N et al. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism in uremia. J Am Soc Nephrol 2002; 13:1490\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","volume":"67","author":"C.J. Haven","year":"2007","unstructured":"Haven CJ, van Puijenbroek M, Tan MH et al. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol (Oxf) 2007; 67:370\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03347413","volume":"30","author":"A. Agha","year":"2007","unstructured":"Agha A, Carpenter R, Bhattacharya S et al. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Invest 2007; 30:145\u20139.","journal-title":"J Endocrinol Invest"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4065\/77.8.866","volume":"77","author":"S. Dionisi","year":"2002","unstructured":"Dionisi S, Minisola S, Pepe J et al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc 2002; 77:866\u20139.","journal-title":"Mayo Clin Proc"}],"container-title":["Advances in Experimental Medicine and Biology","SuperMEN1"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-1664-8_8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:35Z","timestamp":1619827235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-1664-8_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781441916624","9781441916648"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-1664-8_8","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}